If this is your company, CONTACT US to activate Packbase™ software to build your portal.
Blueberry Therapeutics
Inflammation & Infection Nanotechnology
Blueberry Therapeutics Ltd. is a modern drug discovery and development company which puts people first whether patients, employees, investors or partners. We have created an open, imaginative and fun team environment with a very serious objective: to create new, safer and more effective medicines to treat human disease and make patients feel better.
Blueberry focuses on the research and development of treatments for inflammatory and infectious diseases. We do this by employing state of the art preclinical research technologies to generate potent selective and safe molecules (peptides, antibodies, small molecules) for clinical development into new effective treatments to benefit patients. By focusing on well validated drug targets and ensuring our candidate molecules have a very low toxicity liability we believe we can mitigate or even avoid two of the major reasons for drug failures in the clinic.
In the clinic, Blueberry uses smart, agile, adaptive clinical designs to deliver high quality trials more rapidly and with reduced development costs. Our adaptive approaches make it possible to discover and rectify inappropriate assumptions during trials without undermining the validity and integrity of the results.
Blueberry will rapidly progress new therapies to clinical proof-of-concepts and beyond with appropriate, effective and safe doses with full regulatory and ethical approval.
We have programs addressing Bacterial Drug Resistance, Ulcerative Colitis, Atopic Dermatitis, Onychomycosis and Tinea Pedis.
